CompoAtlas

Quantis ®spécial Tendance Hyperthyroïdienne

Food supplement declared in France, decision dated 23 October 2026

Quantis ®spécial Tendance Hyperthyroïdienne is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
LPEV
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
10 ml
Directions for use
5 ml 2 fois par jour à diluer dans un verre d'eau
Intended populations
General population
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Pregnant women, Taking thyroid medication
Objectives stated by the manufacturer (these are not authorised claims)
Autre : Tendance Hyperthyroïdienne

Declaration 380244, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Crataegus laevigata (Poir.) DC.BourgeonExtrait fluide aqueux1.2 ml
Lycopus europaeus L.Parties aériennesExtrait fluide aqueux1.2 ml
Viburnum lantana L.BourgeonExtrait fluide aqueux1.2 ml

Additives

E422

Other ingredients

jus de citron

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne peut se substituer à une alimentation variée, équilibrée et à un mode de vie sain. Tenir hors de la portée des enfants. Ne pas dépasser les doses journalières recommandées. Une consommation excessive peut avoir des effets laxatifs. Les enfants de moins de 12 ans, les femmes enceintes ou allaitantes doivent demander l'avis d'un praticien de santé. Les personnes ayant une hypothyroïdie ou un traitement de la thyroïde doivent préalablement consulter un professionnel de santé.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Crataegus laevigata (Poir.) DC.
    Read the warning, when it applies and the studies cited

    Hawthorn

    Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line